Success Metrics

Clinical Success Rate
62.5%

Based on 5 completed trials

Completion Rate
63%(5/8)
Active Trials
0(0%)
Results Posted
80%(4 trials)
Terminated
3(38%)

Phase Distribution

Ph phase_2
2
25%
Ph phase_3
6
75%

Phase Distribution

0

Early Stage

2

Mid Stage

6

Late Stage

Phase Distribution8 total trials
Phase 2Efficacy & side effects
2(25.0%)
Phase 3Large-scale testing
6(75.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

62.5%

5 of 8 finished

Non-Completion Rate

37.5%

3 ended early

Currently Active

0

trials recruiting

Total Trials

8

all time

Status Distribution
Completed(5)
Terminated(3)

Detailed Status

Completed5
Terminated3

Development Timeline

Analytics

Development Status

Total Trials
8
Active
0
Success Rate
62.5%
Most Advanced
Phase 3

Trials by Phase

Phase 22 (25.0%)
Phase 36 (75.0%)

Trials by Status

completed563%
terminated338%

Recent Activity

Clinical Trials (8)

Drug Details

Intervention Type
DRUG
Total Trials
8